Back to mobile site

Wolfe Research on Compass Pathways (CMPS): 'we expect the stock to regain strong momentum after this pullback'

July 7, 2026 3:52 PM EDT Send to a Friend
Wolfe Research analyst Rudy Li reiterated an Outperform rating and $18.00 price target on Compass Pathways (NASDAQ: CMPS).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login